AN1 0.00% 0.8¢ anagenics limited

Ann: Preliminary Final Report, page-122

  1. 475 Posts.
    lightbulb Created with Sketch. 214
    This is a sober and candid assessment of Cellmid's position and where it is heading. Retail and distribution business is very competitive and risky be it health or beauty products. We could burn all our cash with little to show vis-a-vis revenue and profit. Worrying times to say the least.
 
watchlist Created with Sketch. Add AN1 (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.